Skip to main content

Why the Mini-Mental State Examination (“MMSE”) Copyright Has No Legal Standing




Over a year ago, John Newman and Robin Feldman wrote in the New England Journal Of Medicine about a company, PAR, attempting to assert a copyright over the Mini-Mental State Exam (MMSE).  While I found PAR's enforcement of the copyright morally reprehensible, I had little legal knowledge to know whether their copyright claim had any legal standing.   That has all changed thanks to another fine article by Newman and Feldman in the Stanford Technology Law Review (free to download here). I can now gladly say that my moral disgust is now on equal footing with a firm belief that the law is not on PAR's side.

A Little Background on the MMSE Debacle

Let's take a step back though and remind everyone of what we discussed in some previous GeriPal posts about the MMSE copyright debacle.  The MMSE, despite all of it's flaws, is probably the most commonly used cognitive screening test out their in medicine.  Its widespread use can largely be thanked to several factors, most importantly is that for 30 years it was free for anyone to use and reproduce, as the creators of the MMSE never enforced their copyright.  The MMSE is also not a novel cognitive test, as it is clearly a derivation of other prior cognitive tests.  As discussed in detail in a previous post, the MMSE is:
  • Not the first short cognitive test 
  • Not the first test to include questions on orientation 
  • Not the first test to include registration and recall questions 
  • Not the first test to include attention and calculation (serial 7’s) questions 
  • Not the first test to include repeating a sentence 
  • And not the first test to include overlapping polygons

Should copyright apply to medical testing such as the MMSE?

I encourage anyone interested in learning more about this question to read the Law Review article by Feldman and Newman. I could in no way do it justice in a single post.  What I can do is quote their conclusion which gives the general gist of the article and a harsh rebuke to those trying to assert the copyright of the MMSE:
When a medical test consists of nothing but words, asserting copyright in those words serves as a back door approach for using copyright to gain control of a process—something that is the proper purview of patent law, rather than copyright. The logic would apply in all such testing, but the assertion of copyright in the Mini-Mental State Exam, is particularly inappropriate. Much of the value of the test flows from its adaptation as an industry standard, rather than the labor of the authors. In addition, the fact that the authors permitted the work to be used freely for decades has created the expectation in users that work would be freely available and has encouraged its adoption as the industry standard. After standing silent for decades, the authors cannot now decide that the test provides a convenient vehicle for monetization

Next Steps

While we wait for someone brave enough to take PAR on in court, I think we should continue to encourage all of our colleagues to avoid strengthening the MMSE's position as the standard for cognitive screens.  This means don't use it and don't teach it.  There are far better test out there that future health care providers should be using in place of the MMSE (SLUMS, MoCA, and Mini-Cog).

Also, something that I just learned thanks to this law review article, we can actually release the results of these alternative cognitive tests with our patients, something that PAR expressively prohibits with the MMSE (apparently it's a violation of PAR's trade secrets to discuss the results with your patients, which I must say, makes the MMSE the worlds worst kept trade secret.)

by: Eric Widera (@ewidera)


For further reading, here are some additional GeriPal posts on the MMSE Copyright Debacle:

Comments

John Newman said…
Thank you, Eric! Robin Feldman is truly a gifted legal writer, and I encourage anyone who is interested in the subject to give the article a read. It's not only about the MMSE, although it have become the poster child for a dysfunctional system. We have a chance to fix that system before it becomes entrenched in the clinical world, and the article offers a blueprint for how.
MedEdDoctorMom said…
I will definitely read the legal piece, but I'm stuck - in Ontario, Canada, if my patients want to take cholinesterase inhibitors, I need them to have an MMSE score between 10 and 26 (don't get me started... I know it makes zero sense) -it's a government rule. (Note- not trying to start a debate about cholinesterase inhibitors! :) However, whether they are chosen by patients/families should not be dictated by the MMSE...)
Dr Pullen said…
This along with the human genome ruling give hope to those of us who would like to think our laws and doing the right thing may have something in common. Thanks for the article.
Bruce Scott said…
Please keep on talking about this Eric. It's important.

I currently don't let any students, residents, or fellows slip past an MMSE score without them hearing about it.

It helps that there are multiple superior alternatives as well. Due to PAS's despicable anti-academic bullying, Sweet 16 is no longer publicly available, but MOCA and SLUMS are (and the Mini-Cog will get you as much as an MMSE in a lot less time). The hypocrisy involved with going after Fong, and colleagues is breathtaking, since the MMSE was completely derivative on previous work. It might be harder for some of us to take a stand if it were clearly superior test. The fact that it is clearly completely inferior should make it pretty painless to go cold turkey.

Popular posts from this blog

Caring, and the Family Caregivers We Don’t See

Over lunch at a restaurant in Manhattan, my father and I talked about long-term care insurance and the emergence of senior centers and nursing homes across the U.S. that offer a variety of ethnic cuisines and cultural events, catering not only to a growing population of adults over 65, but also, to an increasingly diverse population of adults who call the U.S. their home. This conversation was different from many similar ones before it – we weren’t talking about my research; we were talking about our own lives.
My parents immigrated to the U.S. in the late ‘70s and early ‘80s, following their parents’ advice on professional opportunities that seemed unimaginable in India at the time. Although they considered moving back soon after to care for their aging parents and to raise children, they ultimately decided to stay in the U.S. As I chronicled earlier, my paternal grandparents lived with us until I completed middle school, at which point they returned to India and lived with my mater…

Practical Advice for the End of Life: A Podcast with BJ Miller

This week we talk with BJ Miller, hospice and palliative care physician, public speaker, and now author with Shoshana Berger of the book "A Beginner's Guide to the End."

As we note on the podcast, BJ is about as close as we get to a celebrity in Hospice and Palliative Care.  His TED Talk "What Really Matters at the End of Life" has been viewed more than 9 million times.  As we discuss on the Podcast, this has changed BJ's life, and he spends most of his working time engaged in public speaking, being the public "face" of the hospice and palliative care movement.

The book he and Berger wrote is filled to the brim with practical advice.  I mean, nuts and bolts practical advice.  Things like:
How to clean out not only your emotional house but your physical house (turns out there are services for that!)Posting about your illness on social media (should you post to Facebook)What is the difference between a funeral home and mortuaryCan I afford to die?  …

Top 25 Studies in Hospice and Palliative Care (#HPMtop25)

by: Kara Bishoff (@kara_bischoff )

Back in 2015 we wrote a post asking for input on what articles should belong on a list of the top 25 articles in hospice and palliative care.   We decided to focus on hospice palliative care studies and trials - as opposed to review articles, consensus statements and opinion pieces.

Here’s what we came up with. It was hard to pick just 25! We highly prioritized clinical utility and tried to achieve diversity & balance. Many others are worthy of inclusion. Take a look and let us know if you have suggested changes for next year.

Module 1: Symptom Management
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients. Tarumi Y et al. JPSM, 2013.Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study. Currow DC et al. JPSM, 2011.Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomise…